DiaCarta is Changing the Landscape of Precision Molecular Diagnostics
DiaCarta, a translational genomics and precision molecular diagnostics company, was established in 2011 to provide highly sensitive and advanced technologies that will improve the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. With over 80 global patents, DiaCarta offers a range of products and services, from single-gene cancer mutation detection qPCR assays, colorectal cancer mutation detection panels, radiation therapy toxicity monitoring cfDNA test to its targeted NGS panels.
With over 27,000 square feet dedicated to a GMP-compliant lab space as well as CLIA and ISO 13485 certifications, a clinical laboratory facility in Nanjing, and offices in Shanghai, China. DiaCarta is well-equipped to serve clinical laboratories around the world. DiaCarta’s Clinical Service Lab at Nanjing, China is the world’s largest sequencing

Compliance
We are committed to designing and manufacturing products with the good of the patient in mind. We will continuously improve our quality management systems, comply with all applicable regulatory requirements, and build customer confidence by delivering excellent products and services.

Leadership

Aiguo Zhang, Ph.D.

Paul Okunieff, M.D.

Michael Sha, Ph.D.

Ramanathan Vairavan, Ph.D

Hongjun (Harry) Yang, Ph.D.

Michael Acosta

Anne K. Vallerga, Ph.D., MBA

Dennis Gao

Jack Smith

King Lee, Ph.D.

Wei Liu, Ph.D., MBA

Zheng Li, MBBS, MS

C. Mark Lu, M.D.

Effie Ho, Ph.D., MBA

Dr Mauro Scimia

Jack Kaye
Medical & Scientific Advisors

Sir Walter Bodmer FRCPath, FRS

Frank McCormick, Ph.D.

Mickey Urdea, Ph.D.

Dean Tsao, Ph.D.

Anthony M. Magliocco, M.D.
Distributors

Green Vision Co. for Scientific Technologies
Territory: Jordan
Abdul Jawad Hassouneh Complex
Khalid Bin Al Waleed Street
Jabal Al Hussein, Amman
Jordan
Tel: +962 6 5688336
E-Mail: mohammad@greenvisionsci.com

VNTAB., Jsc
Territory: Viet Nam
Floo2, 49/1295 Giai Phong
Hoang Mai
Ha Noi
Viet Nam
Tel: (84) 2462844446/7/9
E-Mail: sales@tabc.com.vn
Certificates
Awards
CIO Applications
Top 25 Life Sciences Technology Vendors 2018
The positioning is based on an evaluation of DiaCarta’s



med-tech outlook
Top 10 In-Vitro Diagnostic Technology Solution Providers 2018
The positioning is based on an evaluation of DiaCarta’s specialty in genomic testing for biomarkers, personalized diagnostics and clinical sample testing service provided in their CLIA-certified lab.
CIO Bulletin
One of the 30 Fastest Growing Companies of 2018
The positioning is based on DiaCarta’s revenue growth, financial status, openness to innovation, global collaboration and partnership, flagship products launching, regulatory progress and ability to forecast future business and technology trends..



The Silicon Review
50 Innovative Companies to Watch in the Year 2018
Winning a spot on this list indicates DiaCarta has distinguished itself from peers by proving itself more valuable in terms of service quality, vast customer base, innovation, and market position
Corporate Governance
Certifications & Awards
CIO Applications
Top 25 Life Sciences Technology Vendors 2018
The positioning is based on an evaluation of DiaCarta’s
med-tech outlook
Top 10 In-Vitro Diagnostic Technology Solution Providers 2018
The positioning is based on an evaluation of DiaCarta’s specialty in genomic testing for biomarkers, personalized diagnostics and clinical sample testing service provided in their CLIA-certified lab.
CIO Bulletin
One of the 30 Fastest Growing Companies of 2018
The positioning is based on DiaCarta’s revenue growth, financial status, openness to innovation, global collaboration and partnership, flagship products launching, regulatory progress and ability to forecast future business and technology trends..